Systemic Therapy in the Curative Treatment of Head-and-Neck Squamous Cell Cancer: Cancer Care Ontario Clinical Practice Guideline | Zendy

Eric Winquist | Zendy; Chika Agbassi | Zendy; Brandon M. Meyers | Zendy; John Yoo | Zendy; Kelvin Chan | Zendy

Open Access

Systemic Therapy in the Curative Treatment of Head-and-Neck Squamous Cell Cancer: Cancer Care Ontario Clinical Practice Guideline

Author(s) -

Eric Winquist,

Chika Agbassi,

Brandon M. Meyers,

John Yoo,

Kelvin Chan

Publication year - 2017

Publication title -

current oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.053

H-Index - 51

eISSN - 1718-7729

pISSN - 1198-0052

DOI - 10.3747/co.24.3489

Subject(s) - medicine , cetuximab , guideline , head and neck cancer , cancer , randomized controlled trial , clinical trial , induction chemotherapy , concomitant , radiation therapy , laryngectomy , oncology , intensive care medicine , surgery , larynx , colorectal cancer , pathology

The aim of the present work was to make recommendations about the use of systemically administered drugs in combination or in sequence with radiation (rt) or surgery, or both, for cure or organ preservation, or both, in patients with locally advanced nonmetastatic (stages iii-ivb) squamous cell carcinoma of the head and neck (lascchn).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research